pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-2116 |
Genomic Coordinates | chr15: 59171183 - 59171262 |
Description | Homo sapiens miR-2116 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-2116-5p | |||||||||||||||||||||
Sequence | 14| GGUUCUUAGCAUAGGAGGUCU |34 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | 454 | |||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | GRPEL2 | ||||||||||||||||||||
Synonyms | Mt-GrpE#2 | ||||||||||||||||||||
Description | GrpE like 2, mitochondrial | ||||||||||||||||||||
Transcript | NM_152407 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on GRPEL2 | |||||||||||||||||||||
3'UTR of GRPEL2 (miRNA target sites are highlighted) |
>GRPEL2|NM_152407|3'UTR 1 AGAGGCCATCAGGAACTGGATGTTCTCCCAGAGCGCAGTCACCTATGTTTCTTTTATTTATTAAACTAGGTTTGTATTGT 81 ACATGAGGTACTTCATGTGATATGTTTTGGATTTAGTCATATTGGCTTTATTTCTAAGATATTCTATTGATTTAATGTGA 161 CCTGTTTGGTCTCATCAGAAGTCTTACCATTGGGCATTTGAACAGTGTGACAGGTGTTCCAATGGCCTTTATCAAAACAT 241 GTTTAGGAAAATTGGTACTGTGATAAATTTGAATCCAAAATCCTTTTAACTATGGGTTTTCAACTACATGTTTCTTCCTA 321 GCGGTCTCTATAACAGGAATTGTGTAGTATCTTGTATTTTGTGGAAAAAGGAGATGGTAGGGATTGGTTCAACATTTGGG 401 TACTTAGAGGATAAAGCTTCGTGGTCGTATAAATTTAGATCATTTGGATTGATTTTTATACACATAGATTTTCAGGACTT 481 TACCTTTTGTTTTGTTTTTTTCCTTTTAGCCATCTTTTGTTCTTGTAATCCCAACTAGATAGGCTTTATGCTCACATCAT 561 TGTCCCATACCCACCCCTTTCTCATCCCCATTTGCAGGGGCTAAAGGTCTAGATGAGACTTGGAAGGCAAGGAGCATCGA 641 AATTTGAGATACCCAGGACCCTTTCAAGCAAGAATGGCCAAAAAGCCTTGTGCTGTCTTTGCTCTTCAAATTATTTTCAG 721 CCTCCTTGTCATATAATCATTTCAGGCAAACTGAGGCAACACTAACAGCTAATGACCCAGATGGCTCTATTTGGGTAATT 801 TACCTACAACTTATTCCACCAGCCTTTACTCCTCTGCCCTTTTGTCAATTTTACCTTATAATCCTTTATTAAATGATGGG 881 AGGTGGTGATCAGGACAAAAGTGTTAGGTTCCCATGATTTCTCATTTCATTTATTAATAGTTAATGCTGAATTTTTTTTT 961 AAGTTTCCTCTGGCTCTATTTATGTTACTTTTTGCGATAAGAACACTTAACATAAGTATTCTCTCCTCTTGGCAATTTTT 1041 TTTTTTTTTCCTGTGTTGCCCAGGCTGACCTCCAACTCCTGGGCCCAAGCAATCCTGCCTCAGCCTGCCAAGTAGCTAGG 1121 ACTACAGGCGTTCACCACTGCGCCCGCAAAGTTTTTTTGTTGTTTTTTTTTTTAAGTTGGTACTCACAAATCACTACCTC 1201 TGTTATATTGACAAGCTCTATTTCCTATTCTTTGTATCTGTTAAGTCACATCTGTGTAAACATTGAGCTCACCTTTTATA 1281 TATTAACCTCTAGAATTAATGGGCCTATGTGGTTTTTTTTCAGTCTTATAGCTGGTGTTCTGTAAAAGATTTGTCCAATA 1361 AACGACTTAATGAATGATACATCAGTCAGATTTTAGGAAGGCAGTCAATTATGGATATTTTAATGTTGGAAGAGGCCTTA 1441 ATGATCAAATCTCACCCTTTCTGCTTCTGAAGTATGAAAATCTAGTCTTTTTAGGACTGGACACAAGGAAAATAATCTCT 1521 AAACTATTGACTAAATTCCAGTGAGAGTATGAATGAAGAACAACTAGATATTAATGTCAATCATTTAAGATTAATGGGCA 1601 TGCAATTAAGTCTCCATTTAAGATTAATGGGCATGCAATGAAGTCTCCAGCAGACAATCAGATGTTGTTGGATGTCTAGA 1681 TTATATAGGTTTAGGTTGAAGTTATAAAATAAAATAAAATTCATTTTCCACTGGAACTCTATGACATTCAGTGGAGTGGT 1761 GGAAAGTTAACCTCTTATACATTATAGATAATTCTAAGACAGCACACAAACTTATCAATAAAGCCATCTCCTTGTGGGCC 1841 TTACCATCTTCATCAGATTTAGACCCTTAAAAAACAAGTAAATATGCACTTTTAAAATGCAATCAAAAGACTGGTGGTTA 1921 AGCTTGTAAAACCAGAACATCTTTTGGCATTCCACTAAGTATATATTGTAAATTTAATGAACAATCAAGGTTCACAATAG 2001 GAAGTTGTCTTTTTTTGCCTTCCATTCTGTGAGATTTGACAGATGGTGACAATAAGAAAATGAGCTGATTGTAATTACTC 2081 TCTGTGTGTTTTTTTATTGCTAGCTATCATTACCAGTTAGAATTAACATTAATTACAATTAACAATAATTTTAGGTATGG 2161 AATGTTATGATTACCTAAAGAGATGTCTCTACCTAATGAGCTCAAGTGATCCTCCCACCTCAGCCTACCAAGTAGCCAGG 2241 ACCACAGGCAAGTGCACCACCATGACTGGCTAGTTTTGTTTTTTGGTTTTTGGTTTTTGGTTTTTGGTTTTTTTTTTTTG 2321 GTTGGTTGGTTGTTTTTTACAGGCGGGGTCTCACTATATTGTCCAGGCTAGAAGAATTTTCTAATGGTCTATTACACCTC 2401 CCGTTTTGGCAAGTAAATTCAGAATAATTTTAGGTTCTTTTGTTATTCAGTAGTTTTGCAGACTTAAAAGTGTAAATTTA 2481 GAATTAGAAGATGAAGCTATAGTAGTAAGAATCTCAAGCTGAAGGGCTTTGGGGAGCCAAAGCAGCATATTAGAGCATAG 2561 GCTTGAACTTAAATCTCAGCTCAGTCACCTGCAGGACTTTAGGCACCAGTGATTTCACCCTTCTGAGCCTGTTTCTTTAT 2641 TCGTAAAATGATTATAATAATTCTTTCACAGCGTTGTGAGGATTAAGTGAAATGTGTTAAATGCCTACTACAGTAGGTGC 2721 TCAGATATTTATTTTTATTTTTTTATTATGCACATTGTTTTTCCTGCCTTTTTATGGCTGTCTAAAGTCTAGGGAAAAGG 2801 GAAGACTGGTTAATGATGAGTAGAAAAAACTTGTAAGCTAATCATTCACTGACTTATTTTCCTTCCATTTTCTGGTTTTT 2881 AAAATTAGCCACACCACAGGAAACCCACATTTTTAGATGGAAAGAGCAAGAAAATTGTGTCAGTGCTCTTAGTTATTTTC 2961 ATCTTAATGGTATAGTGAAAAGACATTGACTTGAGATGATACTAAGGAAGCTTTGGCTCACTCTCACTTGAAGAGGGGAT 3041 CTTGGTGTTGTAGTACTTGGACTGTACAAATGTTTTACTGACTTTTCTTACTGCTGTAAAGGAATCAGGCAGTTGGGTAT 3121 TGATATGTTATTTGGTGCTCTCATTCATGGCAAAGGATTTGATAAATAAAAGTTCTTTAAACACTAAAGCAAAATCAAAT 3201 GAGCAAAACTAAGGATGAAATGTAATATTCATCAGAACAAGGATCACTGAGAAAAAATATTCAGAAACAACTTTAATAAA 3281 ACCTGAATTGAAATAACTGCA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000329271.3 | 3UTR | UUUCCUCUGGCUCUAUUUAUGUUACUUUUUGCGAUAAGAACACUUAACAUAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
62 hsa-miR-2116-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT080547 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 2 | ||||||||
MIRT135054 | ADSS | adenylosuccinate synthase | 2 | 4 | ||||||||
MIRT147317 | KPNA2 | karyopherin subunit alpha 2 | 2 | 4 | ||||||||
MIRT154323 | CEBPB | CCAAT/enhancer binding protein beta | 2 | 2 | ||||||||
MIRT326799 | SYAP1 | synapse associated protein 1 | 2 | 2 | ||||||||
MIRT357963 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 2 | ||||||||
MIRT384296 | GOLT1B | golgi transport 1B | 2 | 2 | ||||||||
MIRT442316 | UBE2Q1 | ubiquitin conjugating enzyme E2 Q1 | 2 | 2 | ||||||||
MIRT443785 | ST13 | ST13, Hsp70 interacting protein | 2 | 2 | ||||||||
MIRT446868 | NBPF3 | NBPF member 3 | 2 | 2 | ||||||||
MIRT447647 | RAB3GAP1 | RAB3 GTPase activating protein catalytic subunit 1 | 2 | 2 | ||||||||
MIRT448470 | SLC45A4 | solute carrier family 45 member 4 | 2 | 2 | ||||||||
MIRT449121 | XRRA1 | X-ray radiation resistance associated 1 | 2 | 2 | ||||||||
MIRT450245 | TRIM66 | tripartite motif containing 66 | 2 | 2 | ||||||||
MIRT450270 | F2RL2 | coagulation factor II thrombin receptor like 2 | 2 | 2 | ||||||||
MIRT450688 | RPN2 | ribophorin II | 2 | 2 | ||||||||
MIRT481123 | AZIN1 | antizyme inhibitor 1 | 2 | 4 | ||||||||
MIRT497207 | CDH7 | cadherin 7 | 2 | 4 | ||||||||
MIRT502956 | CCNT2 | cyclin T2 | 2 | 2 | ||||||||
MIRT509226 | KIF14 | kinesin family member 14 | 2 | 6 | ||||||||
MIRT515395 | ARHGAP21 | Rho GTPase activating protein 21 | 2 | 4 | ||||||||
MIRT525559 | MTRNR2L7 | MT-RNR2-like 7 | 2 | 6 | ||||||||
MIRT525608 | MTRNR2L3 | MT-RNR2-like 3 | 2 | 4 | ||||||||
MIRT533254 | VCAM1 | vascular cell adhesion molecule 1 | 2 | 2 | ||||||||
MIRT535782 | MTRNR2L11 | MT-RNR2-like 11 | 2 | 6 | ||||||||
MIRT535803 | MTRNR2L10 | MT-RNR2-like 10 | 2 | 4 | ||||||||
MIRT543211 | TMEM117 | transmembrane protein 117 | 2 | 2 | ||||||||
MIRT552792 | YAF2 | YY1 associated factor 2 | 2 | 2 | ||||||||
MIRT553947 | STAMBP | STAM binding protein | 2 | 2 | ||||||||
MIRT556217 | MB21D2 | Mab-21 domain containing 2 | 2 | 2 | ||||||||
MIRT566351 | POLDIP2 | DNA polymerase delta interacting protein 2 | 2 | 2 | ||||||||
MIRT568429 | GDNF | glial cell derived neurotrophic factor | 2 | 2 | ||||||||
MIRT568521 | ANP32E | acidic nuclear phosphoprotein 32 family member E | 2 | 2 | ||||||||
MIRT573359 | PDE3A | phosphodiesterase 3A | 2 | 2 | ||||||||
MIRT574653 | LMAN2 | lectin, mannose binding 2 | 2 | 2 | ||||||||
MIRT608172 | ERBB2 | erb-b2 receptor tyrosine kinase 2 | 2 | 2 | ||||||||
MIRT610692 | FAM89A | family with sequence similarity 89 member A | 2 | 2 | ||||||||
MIRT618459 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT622281 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT624615 | B3GALT5 | beta-1,3-galactosyltransferase 5 | 2 | 2 | ||||||||
MIRT631041 | TAS2R30 | taste 2 receptor member 30 | 2 | 2 | ||||||||
MIRT638335 | RCAN1 | regulator of calcineurin 1 | 2 | 2 | ||||||||
MIRT641630 | KIAA1244 | ARFGEF family member 3 | 1 | 1 | ||||||||
MIRT649117 | SRD5A1 | steroid 5 alpha-reductase 1 | 2 | 2 | ||||||||
MIRT652246 | TPI1 | triosephosphate isomerase 1 | 2 | 2 | ||||||||
MIRT659865 | CAPRIN1 | cell cycle associated protein 1 | 2 | 4 | ||||||||
MIRT669219 | CAND1 | cullin associated and neddylation dissociated 1 | 2 | 2 | ||||||||
MIRT682585 | CPA4 | carboxypeptidase A4 | 2 | 2 | ||||||||
MIRT690129 | EPHX2 | epoxide hydrolase 2 | 2 | 2 | ||||||||
MIRT699793 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 2 | ||||||||
MIRT699991 | RPS24 | ribosomal protein S24 | 2 | 2 | ||||||||
MIRT710376 | LMBR1 | limb development membrane protein 1 | 2 | 2 | ||||||||
MIRT710412 | YTHDC1 | YTH domain containing 1 | 2 | 2 | ||||||||
MIRT710574 | TNPO1 | transportin 1 | 2 | 2 | ||||||||
MIRT712045 | STYK1 | serine/threonine/tyrosine kinase 1 | 2 | 2 | ||||||||
MIRT713292 | ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif 20 | 2 | 2 | ||||||||
MIRT718211 | TNRC6C | trinucleotide repeat containing 6C | 2 | 2 | ||||||||
MIRT718809 | SLC25A33 | solute carrier family 25 member 33 | 2 | 2 | ||||||||
MIRT719341 | VGLL4 | vestigial like family member 4 | 2 | 2 | ||||||||
MIRT720841 | C1orf52 | chromosome 1 open reading frame 52 | 2 | 2 | ||||||||
MIRT724076 | NCKAP1L | NCK associated protein 1 like | 2 | 2 | ||||||||
MIRT724602 | AP3B1 | adaptor related protein complex 3 beta 1 subunit | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|